Binaytara Launches OncoBlast App Featuring the World's First CME-Accredited Oncology-Centered Game-Based Activities

BELLEVUE, Wash., July 22, 2025 /PRNewswire/ -- Binaytara announces the launch of the full version of OncoBlast, the world's first game-based application that provides free CME-accredited, oncology-centered courses to healthcare professionals. OncoBlast combines expert oncology education with an engaging gaming experience, providing an innovative way for oncology practitioners to stay up-to-date on the constantly evolving landscape of the latest cancer treatment breakthroughs.

OncoBlast features courses reviewed by leading oncologists and experts in every major cancer type, from thoracic oncology to hematology and breast cancer. Each course contains accurate medical data, consistently updated with the latest developments in clinical treatment and care delivery in oncology. Key features of OncoBlast:

• Educational and Engaging Game Modes: Players can challenge themselves in various game modes that are both exciting and educational.
• Progress Tracking: Users can track their progress to keep the learning experience fresh and engaging.
• Global Leaderboard: Compare medical knowledge against other physicians and healthcare providers.
• MOC/CME Credit: Claim American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points and/or American Medical Association Physician's Recognition Award (AMA PRA) Category 1 Credit™ as users finish courses.
• Fellowship Board Prep: Sharpen your knowledge to prepare for your boards.
• New content updated and new courses added periodically: Players will continually have opportunities to learn the latest in cancer treatment.

Dr. Binay Shah, co-founder and president of Binaytara, shared the genesis of the app: "This is a dream come true. It started when I was on a flight and the person sitting next to me was so engaged in a game on her phone. I asked what she was playing and she said 'Candy Crush.' An idea struck me: what if we created a version for cancer, like Cancer Crush? OncoBlast is more than just a gaming app; it has the potential to democratize how we approach medical education in oncology. By gamifying the learning process and providing access to the latest medical data and experts, we're making it easier and more enjoyable for healthcare professionals to advance their knowledge and provide the best care for their patients."

Research has shown that game-based and/or gamified educational activities enhance learning, knowledge retention and provide overall positive experience for the students.

OncoBlast is available for download now on iOS. Join the global community of oncology professionals, enhance your knowledge, and make a difference in the world of cancer care.

Binaytara is dedicated to improving healthcare by providing innovative educational tools and opportunities for healthcare professionals worldwide. OncoBlast represents a significant advancement in medical education, blending easy global access and engaging entertainment in a way that has never been done before with cancer CME. Binaytara leverages its vast network of oncology and hematology faculty from the more than 50 CME-accredited conferences that Binaytara organizes annually across the US to produce world-class courses in OncoBlast.

For more information about OncoBlast by Binaytara, visit binaytara.org/projects/oncoblast

OncoBlast on Apple App Store
OncoBlast on Google Play

Courses include:

• Best of Hematology and Breast Cancer II
• Targeted Therapy in Breast Cancer: Integrating Precision Oncology Into Real-World Clinical Practice
• Clinical Decisions in Lymphoid Cancers: Real-World Case Insights
• Personalized Lung Cancer Care: Updates on Efficacy, Toxicity, and Clinical Decision-Making
• OncoBlast-Biomarkers & Immunotherapy in Precision Oncology
• Precision Oncology in GI Cancer: Integrating Biomarkers Into Clinical Practice
• Advances in Lymphoma: Evidence-Based Decision-Making in Diagnosis and Treatment
• Navigating Multiple Myeloma Therapy: Toxicity, Timing, and Treatment Choice
• GU Oncology II
• Advances in GI Cancer Care: Case-Based Approaches to Modern Therapy
• Best of Hematology and Breast Cancer I
• Precision Oncology in GU Cancers: Biomarkers, Sequencing, and Toxicity Management
• Targeted and Systemic Therapies in Advanced Sarcoma: A Case-Based Learning Module
• Thoracic Oncology Updates from ASCO 2025
• Personalizing NSCLC Treatment: Biomarkers and Targeted Options I
• Personalizing NSCLC Treatment: Biomarkers and Targeted Options II
• Precision Oncology in GU Malignancies: Applying Biomarkers to Clinical Practice
• Optimizing Immuno-Oncology: Innovations in Immune Checkpoint Inhibitor Delivery
• GI Oncology Highlights from ASCO 2025: Practice-Changing Trials You Need to Know
• Navigating the Shift: New NCCN Guidelines and Emerging Therapies in First-line mUC and MIBC
• Managing Multiple Myeloma: Case-Based Clinical Decisions
• Managing CAR T and Bispecific Therapies: A Case-Based Review
• Frontline and Relapsed Management in B-Cell Lymphomas: What the Data Says
• Malignant Hematology: MDS, AML, MPN and ALL
• Multiple Myeloma

About Binaytara:
Binaytara is a leader in global oncology dedicated to eliminating cancer disparities worldwide. As the largest organizer of hematology/oncology conferences in the United States, Binaytara educates thousands of oncology and hematology practitioners in staying current on cutting-edge treatments for their patients. Binaytara's impact extends globally, partnering with local health organizations and governments to establish cancer care centers, improve healthcare access and outcomes through advocacy, foster innovative research in implementation science, and strengthen continuing education programs.

Website: Binaytara.org
X: @Binaytara
Instagram: @Binaytara
LinkedIn: Binaytara

SOURCE Binaytara